These final results, along with a prior report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,two help the concept of focusing on ACKR3 as a unique approach to modulate the opioid procedure, which could open new therapeutic avenues for opioid-associated disorders.These final results advise that conolid